These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28927233)

  • 1. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
    Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
    Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib.
    Luo H; Quan J; Xiao H; Luo J; Zhang Q; Pi G; Ye Y; He R; Liu Y; Su X; Zhao L; Wang G
    Oncol Rep; 2018 May; 39(5):2270-2278. PubMed ID: 29517107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma.
    Maehara O; Suda G; Natsuizaka M; Shigesawa T; Kanbe G; Kimura M; Sugiyama M; Mizokami M; Nakai M; Sho T; Morikawa K; Ogawa K; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Okubo N; Ohnishi S; Takeda H; Sakamoto N
    Cancer Biol Ther; 2021 Jun; 22(5-6):372-380. PubMed ID: 34224333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
    Saito S; Morishima K; Ui T; Hoshino H; Matsubara D; Ishikawa S; Aburatani H; Fukayama M; Hosoya Y; Sata N; Lefor AK; Yasuda Y; Niki T
    BMC Cancer; 2015 Feb; 15():82. PubMed ID: 25884729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
    Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma.
    Bao S; Ji Z; Shi M; Liu X
    Pathol Res Pract; 2021 Dec; 228():153682. PubMed ID: 34784520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.
    Shi Y; Liu X; Fredimoses M; Song M; Chen H; Liu K; Lee MH; Dong Z
    J Cell Biochem; 2018 Feb; 119(2):2231-2239. PubMed ID: 28857247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma.
    Wang H; Zhang Y; Yun H; Chen S; Chen Y; Liu Z
    Oncotarget; 2017 Jul; 8(28):45249-45258. PubMed ID: 28431406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.
    Fisher MM; SenthilKumar G; Hu R; Goldstein S; Ong IM; Miller MC; Brennan SR; Kaushik S; Abel L; Nickel KP; Iyer G; Harari PM; Kimple RJ; Baschnagel AM
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):793-803. PubMed ID: 32298810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547.
    Delpuech O; Rooney C; Mooney L; Baker D; Shaw R; Dymond M; Wang D; Zhang P; Cross S; Veldman-Jones M; Wilson J; Davies BR; Dry JR; Kilgour E; Smith PD
    Mol Cancer Ther; 2016 Nov; 15(11):2802-2813. PubMed ID: 27550940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
    Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
    Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
    Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
    Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
    Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
    Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.